Lin Shao-Lee

CIK 00017250925 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001725092

Recent Transactions

50 trades

Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2025-05-14+1,333→ 1,333 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2024-06-05+1,333→ 1,333 total
Sale
ACELYRIN, Inc.
Common Stock
2024-04-01$6.63/sh−9,961→ 1,577,374 total
Sale
ACELYRIN, Inc.
Common Stock
2024-02-20$7.60/sh−15,701→ 1,587,335 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2024-01-09+964,829→ 964,829 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2024-01-09+413,498→ 413,498 total
Sale
ACELYRIN, Inc.
Common Stock
2024-01-02$7.41/sh−10,691→ 1,603,036 total
Other
ACELYRIN, Inc.
Common Stock
2023-10-04+132,236→ 487,205 total
Other
ACELYRIN, Inc.
Common Stock
2023-10-04−1,161,747→ 0 total
Award
ACELYRIN, Inc.
Common Stock
2023-08-16+842,400→ 1,612,434 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2023-05-18+20,000→ 20,000 total
Other
ACELYRIN, Inc.
Common Stock
2023-05-09+677,813→ 677,813 total
Conversion
ACELYRIN, Inc.
Common Stock
2023-05-09+1,161,747→ 1,161,747 total
Other
ACELYRIN, Inc.
Class A Common Stock
2023-05-09−1,107,213→ 0 total
Other
ACELYRIN, Inc.
Common Stock
2023-05-09+1,107,213→ 1,107,213 total
Tax Payment
ACELYRIN, Inc.
Common Stock
2023-05-09$24.69/sh−337,179→ 770,034 total
Other
ACELYRIN, Inc.
Class A Common Stock
2023-05-09−677,813→ 0 total
Other
ACELYRIN, Inc.
Class A Common Stock
2023-05-09−5,070→ 0 total
Other
ACELYRIN, Inc.
Common Stock
2023-05-09+5,070→ 5,070 total
Conversion
ACELYRIN, Inc.
Series B Redeemable Convertible Preferred Stock
2023-05-09−978,314→ 0 total
Conversion
ACELYRIN, Inc.
Series C Redeemable Convertible Preferred Stock
2023-05-09−183,433→ 0 total
Other
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-09−774,788→ 0 total
Other
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-09+774,788→ 774,788 total
Other
ACELYRIN, Inc.
Class A Common Stock
2023-05-09−354,969→ 0 total
Other
ACELYRIN, Inc.
Common Stock
2023-05-09+354,969→ 354,969 total
Other
ACELYRIN, Inc.
Class A Common Stock
2023-05-09−354,969→ 0 total
Other
ACELYRIN, Inc.
Common Stock
2023-05-09+354,969→ 354,969 total
Other
ACELYRIN, Inc.
Class A Common Stock
2023-05-09−349,898→ 0 total
Other
ACELYRIN, Inc.
Common Stock
2023-05-09+349,898→ 349,898 total
Award
ACELYRIN, Inc.
Employee Stock Option (right to buy)
2023-05-04+774,788→ 774,788 total
Award
Third Harmonic Bio, Inc.
Stock Option (right to buy)
2022-10-26+13,667→ 13,667 total
Award
Surrozen, Inc./DE$SRZN
Option (right to buy)
2022-06-07+20,000→ 20,000 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−20,475→ 0 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-06-04+10,240→ 10,240 total
Award
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
2020-01-21+12,262→ 12,262 total
Award
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-21+6,129→ 112,384 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-21$38.25/sh−2,716→ 109,668 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-05+50,344→ 108,703 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2020-01-05−17,982→ 35,966 total
Award
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-05+35,652→ 144,355 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-05$36.10/sh−38,100→ 106,255 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2020-01-05−32,362→ 32,363 total
Tax Payment
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-04$36.10/sh−8,113→ 58,359 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2020-01-04−17,892→ 35,784 total
Exercise/Conversion
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2020-01-04+17,892→ 66,472 total
Award
Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
2020-01-03+36,284→ 36,284 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2019-06-11+10,240→ 10,240 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2019-04-16+20,475→ 20,475 total

Companies

Recent Filings

Address

C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov